Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

计划入组 40 人 · 首次发布于 2012 年 1 月 18 日

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

计划入组 10 人 · 首次发布于 2007 年 7 月 20 日

GMA and Peri in Moderate-late Preterms

计划入组 150 人 · 首次发布于 2019 年 8 月 29 日

Unasnemab

RgIA-5474

RGCA-CV01

RIMA OBEID

Australia

Roma Green Finance

SWAMI RAMA HIMALAYAN UNIVERSITY

India

Ischemic Stroke Pipeline Shows Promise with Novel Therapies in Development

Spinal Cord Injury Treatment Market Poised for Growth with Emerging Therapies

Costco Partners with Sesame and IVI RMA to Transform Fertility Care Access with 80% Medication Savings